Colonic angioectasia in an adolescent boy with Hoyeraal-Hreidarsson on long-term anabolic steroid therapy

Racha Khalaf, Carmelo Cuffari

Research output: Contribution to journalArticle

Abstract

Androgen therapy has proven efficacy in treating patients with bone marrow failure who are not candidates for bone marrow transplantation. Herein, we report on a case of colonic angioectasia secondary to oxymetholone use in an adolescent patient with Hoyeraal-Hreidarsson syndrome (HHS). A 13-year-old Caucasian male with HHS characterized by cerebellar hypoplasia, developmental delay, microcephaly, esophageal strictures and myelodysplasia presented with severe hematochezia from colonic angioectasia secondary to long-term oxymetholone therapy. These vascular lesions resolved spontaneously once this anabolic steroid was discontinued. While androgen therapy is often recommended for certain anemias and myelodysplastic syndromes, clinicians should be aware of the potential complication in developing these perceived uncommon colonic angioectasias. Moreover, pediatric gastroenterologists should familiarize themselves in identifying these vascular lesions by colonoscopy, especially among the high risk groups on long-term anabolic steroid therapy.

Original languageEnglish (US)
Pages (from-to)68-71
Number of pages4
JournalPediatric Gastroenterology, Hepatology and Nutrition
Volume21
Issue number1
DOIs
StatePublished - Jan 12 2018

Fingerprint

Testosterone Congeners
Oxymetholone
Androgens
Blood Vessels
Esophageal Stenosis
Microcephaly
Gastrointestinal Hemorrhage
Myelodysplastic Syndromes
Colonoscopy
Therapeutics
Bone Marrow Transplantation
Anemia
Bone Marrow
Pediatrics

Keywords

  • Angioectasia
  • Colon
  • Hoyeraal-Hreidarsson syndrome
  • Testosterone congeners

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hepatology
  • Gastroenterology

Cite this

@article{42b89d972ad74149960c8663582bc200,
title = "Colonic angioectasia in an adolescent boy with Hoyeraal-Hreidarsson on long-term anabolic steroid therapy",
abstract = "Androgen therapy has proven efficacy in treating patients with bone marrow failure who are not candidates for bone marrow transplantation. Herein, we report on a case of colonic angioectasia secondary to oxymetholone use in an adolescent patient with Hoyeraal-Hreidarsson syndrome (HHS). A 13-year-old Caucasian male with HHS characterized by cerebellar hypoplasia, developmental delay, microcephaly, esophageal strictures and myelodysplasia presented with severe hematochezia from colonic angioectasia secondary to long-term oxymetholone therapy. These vascular lesions resolved spontaneously once this anabolic steroid was discontinued. While androgen therapy is often recommended for certain anemias and myelodysplastic syndromes, clinicians should be aware of the potential complication in developing these perceived uncommon colonic angioectasias. Moreover, pediatric gastroenterologists should familiarize themselves in identifying these vascular lesions by colonoscopy, especially among the high risk groups on long-term anabolic steroid therapy.",
keywords = "Angioectasia, Colon, Hoyeraal-Hreidarsson syndrome, Testosterone congeners",
author = "Racha Khalaf and Carmelo Cuffari",
year = "2018",
month = "1",
day = "12",
doi = "10.5223/pghn.2018.21.1.68",
language = "English (US)",
volume = "21",
pages = "68--71",
journal = "Pediatric Gastroenterology, Hepatology and Nutrition",
issn = "2234-8646",
publisher = "Korean Society of Pediartic Gastroenterology, Hepatology and Nutrition",
number = "1",

}

TY - JOUR

T1 - Colonic angioectasia in an adolescent boy with Hoyeraal-Hreidarsson on long-term anabolic steroid therapy

AU - Khalaf, Racha

AU - Cuffari, Carmelo

PY - 2018/1/12

Y1 - 2018/1/12

N2 - Androgen therapy has proven efficacy in treating patients with bone marrow failure who are not candidates for bone marrow transplantation. Herein, we report on a case of colonic angioectasia secondary to oxymetholone use in an adolescent patient with Hoyeraal-Hreidarsson syndrome (HHS). A 13-year-old Caucasian male with HHS characterized by cerebellar hypoplasia, developmental delay, microcephaly, esophageal strictures and myelodysplasia presented with severe hematochezia from colonic angioectasia secondary to long-term oxymetholone therapy. These vascular lesions resolved spontaneously once this anabolic steroid was discontinued. While androgen therapy is often recommended for certain anemias and myelodysplastic syndromes, clinicians should be aware of the potential complication in developing these perceived uncommon colonic angioectasias. Moreover, pediatric gastroenterologists should familiarize themselves in identifying these vascular lesions by colonoscopy, especially among the high risk groups on long-term anabolic steroid therapy.

AB - Androgen therapy has proven efficacy in treating patients with bone marrow failure who are not candidates for bone marrow transplantation. Herein, we report on a case of colonic angioectasia secondary to oxymetholone use in an adolescent patient with Hoyeraal-Hreidarsson syndrome (HHS). A 13-year-old Caucasian male with HHS characterized by cerebellar hypoplasia, developmental delay, microcephaly, esophageal strictures and myelodysplasia presented with severe hematochezia from colonic angioectasia secondary to long-term oxymetholone therapy. These vascular lesions resolved spontaneously once this anabolic steroid was discontinued. While androgen therapy is often recommended for certain anemias and myelodysplastic syndromes, clinicians should be aware of the potential complication in developing these perceived uncommon colonic angioectasias. Moreover, pediatric gastroenterologists should familiarize themselves in identifying these vascular lesions by colonoscopy, especially among the high risk groups on long-term anabolic steroid therapy.

KW - Angioectasia

KW - Colon

KW - Hoyeraal-Hreidarsson syndrome

KW - Testosterone congeners

UR - http://www.scopus.com/inward/record.url?scp=85041589352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041589352&partnerID=8YFLogxK

U2 - 10.5223/pghn.2018.21.1.68

DO - 10.5223/pghn.2018.21.1.68

M3 - Article

C2 - 29383307

AN - SCOPUS:85041589352

VL - 21

SP - 68

EP - 71

JO - Pediatric Gastroenterology, Hepatology and Nutrition

JF - Pediatric Gastroenterology, Hepatology and Nutrition

SN - 2234-8646

IS - 1

ER -